蛋白酶子单元基因表达的协调控制促进了抗压能力,蛋白质稳定性和寿命
Irini Topalidou1, Nicolas Lehrbach2
1Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
GeroScience
|February 17, 2026
概括
一个蛋白质体基因突变破坏了蛋白质平衡,影响了衰老和神经退行. 蛋白酶基因的协调调节对于长寿和健康的衰老至关重要.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 衰老研究研究 衰老研究
背景情况:
- 蛋白质体通过降解受损的蛋白质来维持蛋白质平衡.
- 功能障碍的蛋白质酶和蛋白质聚合与衰老和神经退行性疾病有关.
- SKN-1A/Nrf1是一个关键的转录因子,调节蛋白酶体生物发生.
研究的目的:
- 为了研究pbs-5基因促进体中的特定突变对蛋白质酶调节的影响.
- 了解协调蛋白酶子单元基因表达在生理过程和衰老中的作用.
主要方法:
- 在模型生物体中产生了pbs-5促进体删除突变.
- 分析了蛋白酶子单元的基因表达模式.
- 将突变的影响与SKN-1A/Nrf1无活化进行了比较.
- 评估寿命延长范式. 评估寿命延长范式.
主要成果:
- 从SKN-1A/Nrf1控制中,pbs-5促进体删除脱了pbs-5基因表达.
- 这导致了其他蛋白质酶子单元基因的补偿上调,导致恒温失衡.
- 突变复制了SKN-1A/Nrf1失活的一些,但不是所有的效应.
- 这种pbs-5促进子突变取消了寿命延长.
结论:
- 蛋白酶子单元基因表达的协调调节对于SKN-1A/Nrf1的生理作用至关重要.
- 这种协调的破坏会损害蛋白质体平衡,并对寿命产生负面影响.
- 通过协调基因调节来维持蛋白酶功能对于健康的衰老至关重要.
相关概念视频
The Proteasome
1.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.8K
The Proteasome
10.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.3K
The Proteasome
4.7K
4.7K
Regulation of the Unfolded Protein Response
3.1K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Regulation of Expression at Multiple Steps
1.4K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.4K
Regulated Protein Degradation
3.2K
3.2K


